Copyright
©The Author(s) 2020.
World J Clin Oncol. Jun 24, 2020; 11(6): 378-388
Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.378
Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.378
Figure 2 Disease-free survival in endometrial cancer patients with cancer antigen 125 < 20 U/mL and human epididymis protein 4 < 113 pmol/L compared with patients with cancer antigen 125 ≥ 20 U/mL and/or human epididymis protein 4 ≥ 113 pmol/L.
CA125: Cancer antigen 125; HE4: Human epididymis protein 4.
- Citation: Panyavaranant P, Manchana T. Preoperative markers for the prediction of high-risk features in endometrial cancer. World J Clin Oncol 2020; 11(6): 378-388
- URL: https://www.wjgnet.com/2218-4333/full/v11/i6/378.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i6.378